StockNews.AI
HAE
StockNews.AI
41 days

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025

1. Haemonetics will release Q1 fiscal year 2026 results on August 7, 2025. 2. A conference call for analysts will follow the earnings release. 3. Live webcast of the call available on Haemonetics' investor relations site. 4. Replay of the call accessible one year post-event. 5. Haemonetics focuses on improving healthcare technology and plasma collection.

5m saved
Insight
Article

FAQ

Why Neutral?

The earnings announcement typically does not drastically alter stock perception unless surprises occur. Historical responses to similar earnings reveals mixed reactions based on results.

How important is it?

The scheduled earnings report is significant, but lack of new product announcements or breakthroughs lowers its impact.

Why Short Term?

Investor reactions are likely to materialize immediately post-earnings release, influencing stock price short-term.

Related Companies

ABTBIOPKI
, /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2026 financial results at 6:00 am ET on Thursday, August 7, 2025. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on August 7, 2025. The call can be accessed via teleconference at: Q1 2026 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start. A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/wv7zkgdh  A replay of the conference call and webcast will be available for one year beginning on August 7, 2025 at 11:00 am ET using the conference call webcast link provided in this press release.ABOUT HAEMONETICSHaemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.Investor Contacts: Olga Guyette, Vice President-Investor Relations & Treasury     (781) 356-9763  [email protected]       David Trenk, Manager-Investor Relations(203) 733-4987 [email protected]                                                                                Media Contact:   Josh Gitelson, Sr. Director-Global Communications   (781) 356-9776[email protected] SOURCE Haemonetics Corporation WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News